مرور Volume 13, Issue 3 بر اساس عنوان
در حال نمایش موارد 1 - 6 از 6
-
Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis
(Shiraz Institute for Cancer Research, 2016-09-01)Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system and cytokines may play a role in the development of MS lesions. Objective: To determine ...
-
Effect of TNF-α Blockade in Gingival Crevicular Fluid on Periodontal Condition of Patients with Rheumatoid Arthritis
(Shiraz Institute for Cancer Research, 2016-09-01)Background: Periodontitis and rheumatoid arthritis (RA) share a number of clinical and pathologic features, one of which is the presence of the tumor necrosis factor alpha (TNF-α)-induced bone resorption ...
-
Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus
(Shiraz Institute for Cancer Research, 2016-09-01)Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease which is characterized by B-cell abnormality and auto-antibody generation. Since bacterial infections are the most important ...
-
The Immunostimulatory Effect of Lactic Acid Bacteria in a Rat Model
(Shiraz Institute for Cancer Research, 2016-09-01)Background: Probiotics are “live", beneficial microbes that provide important health benefits in their hosts. There is significant interest in the modulation and regulation of the immune function by ...
-
Maternal Serum and Cervicovaginal IL-6 in Patients with Symptoms of Preterm Labor
(Shiraz Institute for Cancer Research, 2016-09-01)Background: Preterm birth is a common problem in obstetrics. Objective: To measure maternal serum interlukin-6 in mothers with preterm uterine contractions and compare it with ...
-
Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer
(Shiraz Institute for Cancer Research, 2016-09-01)Background: Regulatory T Cells (Tregs) and Myeloid-Derived Suppressor Cells (MDSCs) are two main regulatory cells modulating the immune responses in inflammation and cancer. Objective: To ...



